Radiation therapy for early stage lung cancer

Seminars in Interventional Radiology

Volumn 30, Issue 2, 2013, Pages 185-190

  Parashar, Bhupesh ^a   Arora, Shruthi ^a   Wernicke, A Gabriella ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

HDR; LDR; lung; lung cancer; radiation; stereotactic

Indexed keywords

EID: 84878384698     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0033-1342960     Document Type: Article

References (34)

1. American Cancer Society 2012: Cancer facts and figures. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-031941.pdf. Accessed October: 2012
2. Curran W. J. Jr, Paulus R., Langer C. J., et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst: 2011; 103 19 1452 1460
3. Lee J. S., Hirsh V., Park K., et al. Vandetanib versus placebo in patients with advanced non-small-cell lung cancer after prior therapy with an epidermal growth factor receptor tyrosine kinase inhibitor: a randomized, double-blind phase III trial (ZEPHYR). J Clin Oncol: 2012; 30 10 1114 1121
4. Mouillet G., Monnet E., Milleron B., et al. Intergroupe Francophone de Cancérologie Thoracique (IFCT) Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials. J Thorac Oncol: 2012; 7 5 841 849
5. Ricardi U., Filippi A. R., Guarneri A., et al. Stereotactic body radiation therapy for lung metastases. Lung Cancer: 2012; 75 1 77 81
6. Salama J. K., Kirkpatrick J. P., Yin F. F. Stereotactic body radiotherapy treatment of extracranial metastases. Nat Rev Clin Oncol: 2012; 9 11 654 665
7. Ginsberg R. J., Rubinstein L. V. Lung Cancer Study Group Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg: 1995; 60 3 615 622; discussion 622-623
8. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA: 2010; 303 11 1070 1076
9. Dosoretz D. E., Katin M. J., Blitzer P. H., et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys: 1992; 24 1 3 9
10. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol: 2007; 2 7 03 S94 S100 (Pubitemid 47183602)
11. Lagerwaard F. J., Verstegen N. E., Haasbeek C. J., et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys: 2012; 83 1 348 353
12. Shibamoto Y., Hashizume C., Baba F., et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study. Cancer: 2012; 118 8 2078 2084
13. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol: 2006; 24 30 4833 4839 (Pubitemid 46630909)
14. Song S. Y., Choi W., Shin S. S., et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung Cancer: 2009; 66 1 89 93
15. Nuyttens J. J., van der Voort van Zyp N. C., Praag J., et al. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. Radiother Oncol: 2012; 102 3 383 387
16. Hilaris B. S., Martini N., Wong G. Y., Nori D. Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am: 1987; 67 5 965 977 (Pubitemid 17158578)
17. Tselis N., Ferentinos K., Kolotas C., et al. Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies. J Thorac Oncol: 2011; 6 3 545 552
18. Nori D., Li X., Pugkhem T. Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: a pilot study. J Surg Oncol: 1995; 60 4 257 261 (Pubitemid 26004390)
19. Parashar B., Patel P., Singh P., et al. Management of single malignant lung nodules in elderly patients (70 years or older) who are not candidates for lobectomy. Am J Clin Oncol: 2012; 35 5 480 485
20. Bibault J. E., Prevost B., Dansin E., Mirabel X., Lacornerie T., Lartigau E. Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer. Radiat Oncol: 2012; 7 102
21. Chen V. J., Oermann E., Vahdat S., et al. CyberKnife with tumor tracking: an effective treatment for high-risk surgical patients with stage I non-small cell lung cancer. Front Oncol: 2012; 2 9
22. Agarwal R., Saluja P., Pham A., et al. The effect of CyberKnife therapy on pulmonary function tests used for treating non-small cell lung cancer: a retrospective, observational cohort pilot study. Cancer Manag Res: 2012; 4 347 350
23. Chi A., Jang S. Y., Welsh J. S., et al. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non-small-cell lung cancer or lung metastases. Int J Radiat Oncol Biol Phys: 2011; 81 3 856 862
24. Blasberg J. D., Belsley S. J., Schwartz G. S., et al. Robotic brachytherapy and sublobar resection for T1 non-small cell lung cancer in high-risk patients. Ann Thorac Surg: 2010; 89 2 360 367
25. Ricardi U., Filippi A. R., Guarneri A., et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer: 2010; 68 1 72 77
26. Baumann P., Nyman J., Hoyer M., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol: 2009; 27 20 3290 3296
27. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA: 2010; 303 11 1070 1076
28. Haasbeek C. J., Lagerwaard F. J., Slotman B. J., Senan S. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol: 2011; 6 12 2036 2043
29. Janssen S., Dickgreber N. J., Koenig C., et al. Image-guided hypofractionated small volume radiotherapy of non-small cell lung cancer-feasibility and clinical outcome. Onkologie: 2012; 35 7-8 408 412
30. Peulen H., Karlsson K., Lindberg K., et al. Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. Radiother Oncol: 2011; 101 2 260 266
31. Chen A., Galloway M., Landreneau R., et al. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys: 1999; 44 5 1057 1063 (Pubitemid 29342907)
32. Fleischman E. H., Kagan A. R., Streeter O. E., et al. Iodine125 interstitial brachytherapy in the treatment of carcinoma of the lung. J Surg Oncol: 1992; 49 1 25 28
33. Pisch J., Harvey J. C., Panigrahi N., et al. Iodine-125 volume implants in patients with medically unresectable stage I lung cancer. Endocuriether Hypertherm Oncol: 1996; 12 165 170 (Pubitemid 26260759)
34. Hilaris B. S., Martini N. The current state of intraoperative interstitial brachytherapy in lung cancer. Int J Radiat Oncol Biol Phys: 1988; 15 6 1347 1354 (Pubitemid 19015476)